new glp-1 medications Popular may have health benefits that extend beyond weight loss and blood sugar control, a study finds Retatrutide for weight loss: Study
Description
FDA approval for a new indication for Wegovy (semaglutide) to reduce the risk of major adverse cardiovascular events, including cardiovascular death, heart attack, and stroke, in adults with cardiovascular disease and obesity or overweight
5 Even modest weight loss is clinically meaningful: reductions of 5% of baseline weight can improve blood pressure, glucose levels and cardiovascular risk
PLoS ONE 6 , e27861 (2011)
Savor each bite thoroughly, chewing slowly and concentrating on enjoying the food
